Report title: Taiwan Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
from Global Markets Direct - Market Research
71 page report published Sep 28, 2009

Price $2,500.00 available for immediate download
Report Overview
 
Table of Contents
 
Search Inside
 
About Global Markets Direct - Market...

SummaryThis report is an essential source for in-depth information and data relating to Taiwan drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices market in TaiwanScope- The report provides information on the drug delivery devices market in Taiwan. - Details on the key segments and categories such as Inhalation Systems, Needle Free Injections, and Infusion Systems.- Total revenues, products sold, end users, and average pricing.- Market shares of all the key competitors such as Terumo Corporation, Baxter International Inc., JMS CO., LTD., Fresenius Kabi AG, and B. Braun Melsungen AG. - Key pipeline products that are set to shape the market, broken down by sector. - Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.- Key mergers and acquisitions, partnerships, private equity investments and IPOs. - Customer, hospitals and physicians data.Reasons to buy- Gain a strong understanding of the drug delivery devices market in Taiwan.- Evaluate and compare the attractiveness of the market in the country. - Identify growth segments and opportunities in each industry sector within the country.- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.- Analyze the competitiveness of the market in the country and identify hotspots. - Develop strategies based on the latest product, brand, expansion and research and development news in the country. - Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Source: Global Markets Direct
Document ID: GMDME0940ICR
Country: Taiwan
Industry: Medical Devices & Diagnostics
Free Sample: Click Here to Download
Format:
PDF Adobe Acrobat

Sections
TitleStarting PageNumber of Pages
1 Table of Contents27
1.1 List of Tables62
1.2 List of Figures81
2 Introduction91
2.1 What Is This Report About?91
3 Definitions of Markets Covered in This Report102
3.1 Drug delivery devices101
3.2 Inhalation Systems101
3.2.1 Metered Dose Inhaler101
3.2.2 Dry powder inhaler 101
3.3 Infusion Systems101
3.3.1 Infusion pumps 101
3.3.2 Syringe pumps101
3.3.3 Disposable Infusion sets111
4 Healthcare Sector Review128
4.1 Healthcare Expenditure122
4.2 Healthcare Infrastructure145
4.3 Healthcare Policy 191
5 Regulation System 207
5.1 Medical Equipment Approval Process201
5.1.1 Classification 201
5.2 Pre-market Approval 215
5.3 Fast-track Approval 261
5.4 Registration Period 261
5.5 Labeling and Packaging 261
5.6 Post-market Surveillance 261
6 Pricing and Reimbursement272
6.1 Reimbursement Application 271
6.2 Reimbursement Systems272
7 Distribution Structure 291
8 Drug Delivery Devices In Taiwan3010
8.1 Drug Delivery Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015302
8.2 Drug Delivery Devices, Taiwan, Overall Revenue ($ mn), 2000-2015324
8.3 Drug Delivery Devices, Taiwan, Category Volume (Units), 2000-2015363
8.4 Drug Delivery Devices, Taiwan, Company Share (2007-2008)391
9 Infusion Systems In Taiwan406
9.1 Infusion Systems Overall Revenue (2000-2015) 402
9.2 Infusion Systems Overall Volume (2000-2015) 421
9.3 Infusion Systems Average Price (2000-2015) 431
9.4 Infusion Systems Distribution Share (2007-2008) 441
9.5 Infusion Systems, Taiwan, Company Share (2007-2008)451
10 Inhalation Systems In Taiwan467
10.1 Inhalation Systems Overall Revenue (2000-2015) 462
10.2 Inhalation Systems Overall Volume (2000-2015) 482
10.3 Inhalation Systems Average Price (2000-2015) 501
10.4 Inhalation Systems Distribution Share (2007-2008) 511
10.5 Inhalation Systems, Taiwan, Company Share (2007-2008)521
11 Overview of Key Companies in Taiwan Drug Delivery Devices Market5312
11.1 AstraZeneca PLC 531
11.1.1 Company Overview531
11.2 Boehringer Ingelheim GmbH 531
11.2.1 Company Overview531
11.3 Baxter International Inc. 541
11.3.1 Company Overview541
11.4.1 Company Overview541
11.5 Terumo Corporation551
11.5.1 Company Overview551
11.5.2 Terumo Corporation Pipeline Products551
11.5.2.1 Terumo Corporation Pipeline Products By Equipment Type551
11.5.2.2 Terumo Corporation Pipeline Products By Development Stage551
11.5.2.3 Terumo Corporation Pipeline Products By Therapy Area561
11.5.2.4 Terumo Corporation Pipeline Products By Clinical Trials561
11.5.2.5 Terumo Corporation Pipeline Products By News Summary571
11.6 Cardinal Health, Inc. 581
11.6.1 Company Overview581
11.7 GlaxoSmithKline plc 591
11.7.1 Company Overview591
11.8 B. Braun Melsungen AG 601
11.8.1 Company Overview601
11.9 Smiths Medical 601
11.9.1 Company Overview601
11.10 Fresenius Kabi AG611
11.10.1 Company Overview611
11.11 Consort Medical plc 621
11.11.1 Company Overview621
11.11.2 Consort Medical plc Pipeline Products621
11.11.2.1 Bespak plc Pipeline Products By Equipment Type621
11.11.2.2 Bespak plc Pipeline Products By Development Stage621
11.11.2.3 Bespak plc Pipeline Products By Therapy Area631
11.12 Hospira, Inc. 641
12 Financial Deals Landscape652
12.1 Partnerships651
12.1.1 Novartis Terminates Its Licensing Agreement With NexMed651
12.1.2 Teikoku Pharma Enters Into An Agreement With Eisai661
13 Appendix675
13.1 Global Markets Direct Research Methodology671
13.2 Secondary Research681
13.3 Primary Research681
13.4 Models691
13.5 Forecasts691
13.6 Expert Panel Validation691
13.7 Currency Conversion701
13.8 Contact Us711
13.9 Disclaimer711

Enter the keyword(s) which you would like to search for within this document and click "Search"  


Price: $2,500.00



  Can't Decide?

Purchasing premium research sight unseen can be intimidating. At Alacra we want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.